Xeris Biopharma Holdings, Inc. - stock earnings
XERS Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -13.4 million USD | 44.4 million USD |
| 2023Q3 | -12.2 million USD | 48.3 million USD |
| 2023Q2 | -19.8 million USD | 38.0 million USD |
| 2023Q1 | -16.8 million USD | 33.2 million USD |
| 2022Q4 | -19.8 million USD | 38.0 million USD |
| 2022Q3 | -26.6 million USD | 33.2 million USD |
| 2022Q2 | -26.2 million USD | 25.3 million USD |
| 2022Q1 | -33.7 million USD | 22.1 million USD |
| 2021Q4 | -50.8 million USD | 21.4 million USD |
| 2021Q3 | -26.0 million USD | 11.0 million USD |
| 2021Q2 | -27.5 million USD | 8.9 million USD |
| 2021Q1 | -18.4 million USD | 8.1 million USD |
| 2020Q4 | -21.9 million USD | 7.1 million USD |
| 2020Q3 | -16.0 million USD | 9.4 million USD |
| 2020Q2 | -24.1 million USD | 2.0 million USD |
| 2020Q1 | -29.2 million USD | 1.8 million USD |
| 2019Q4 | -33.1 million USD | 1.9 million USD |
| 2019Q3 | -32.8 million USD | 323000 USD |
| 2019Q2 | -34.4 million USD | 320000 USD |
| 2019Q1 | -25.3 million USD | 248000 USD |
| 2018Q4 | -20.4 million USD | 801000 USD |
| 2018Q3 | -14.8 million USD | 582000 USD |
| 2018Q2 | -13.0 million USD | 819000 USD |
| 2018Q1 | -11.9 million USD | 263000 USD |
| 2017Q4 | -9.1 million USD | 467000 USD |
| 2017Q3 | -7.5 million USD | 170000 USD |
| 2017Q2 | -5.2 million USD | 565000 USD |
| 2017Q1 | -4.6 million USD | 354000 USD |
| 2016Q4 | -13.2 million USD | 1.1 million USD |
XERS Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -62.3 million USD | 163.9 million USD |
| 2022 | -94.7 million USD | 110.2 million USD |
| 2021 | -122.7 million USD | 49.6 million USD |
| 2020 | -91.1 million USD | 20.2 million USD |
| 2019 | -125.6 million USD | 2.7 million USD |
| 2018 | -60.1 million USD | 2.5 million USD |
| 2017 | -26.6 million USD | 1.6 million USD |
| 2016 | -13.2 million USD | 1.1 million USD |
XERS
Price: $1.89
52 week price:
Earnings Per Share: -0.45 USD
P/E Ratio: -6.24
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 485000
Market Capitalization: 266.2 million